|
| Author | Year | Age/sex | How it is diagnosed (LP versus mass) | Treatment and OS |
|
| Gawish [18] | 1976 | 8/M | Left frontoparietal mass extending across midline and through the skull | Complete resection with recurrence. Subtotal resection with Cy. OS of 3 years |
| Valsamis et al. [19] | 1976 | 6 m/M | Left parietal, bilateral temporal, and post pituitary mass with abdominal and periaortic nodal involvement | Resection, steroids, WBRT, and spinal irradiation with recurrence, IT MTX. OS of 23 months |
| Tanaka et al. [20] | 1977 | 49/M | Right thalamus to midbrain mass | Subtotal resection. OS of 4.5 years |
| Tanaka et al. [20] | 1977 | 58/M | Right temporal mass | Subtotal resection. Recurrence. OS 3 months |
| Tanaka et al. [20] | 1977 | 42/M | Left deep parietal to occipital mass | Pred with partial resection. Recurrence. Vincristine and Cy with radiation. Vincristine, bleomycin, Cy, steroids. OS of 2.5 years |
| Giromini et al. [11] | 1981 | 11/M | Left temporooccipital mass | Complete resection |
| Hegedüs [21] | 1984 | 50/F | Right lower parietal lobe mass | Post mortem finding |
| Kobayashi [22] | 1984 | 55/F | Right temporoparietal mass | Complete resection. Recurrence with reresection. OS of 2 months |
| Pui et al. [23] | 1985 | 6/M | T2-5 mass | Laminectomy and CHOP (without prednisone). OS > 2 years |
| Pui et al. [23] | 1985 | 7/M | C7-T4 mass | Laminectomy, radiation, dex, and Cy. Recurrence. OS of 5 months |
| Pui et al. [23] | 1985 | 12/M | T7-10 mass | Laminectomy, CHOP (substituting dex for prednisone). OS of 4 months |
| Mizugami et al. [24] | 1987 | 6/M | T10 mass | Near complete resection, radiation, and chemotherapy. Leukemic transformation then CSF recurrence. IT MTX and cranial irradiation. OS of 20 months |
| Mizugami et al. [24] | 1987 | 5/M | Epidural T12-L4 mass | Near complete resection, radiation, and chemotherapy with recurrence. OS of 7 months |
| Mizugami et al. [24] | 1987 | 7/F | T11 mass | Near complete resection. Spinal radiation and chemotherapy with progression of disease. OS of 3 months |
| Shigemori et al. [25] | 1991 | 49/F | Left frontal lobe mass | Resection, radiation, CHOP, and IT MTX. OS of >6 months |
| Tekkök et al. [12] | 1991 | 5/M | Parasellar mass, extending to bilateral sphenoids and sella turcica | Partial resection, craniospinal radiation, CHOP, and IT MTX/cytarabine/prednisone. OS > 18 months |
| Toren et al. [26] | 1994 | 6/F | CSF | Steroids, IVIG, doxorubicin, vincristine, HD MTX, with IT MTX, cytarabine, and hydrocortisone. Changed to CHOP with MTX and IT MTX, cytarabine, hydrocortisone. OS of >2 years |
| Mora and Wollner [7] | 1999 | 18/M | T11 mass | Laminectomy with CHOP substitute daunorubicin for doxorubicin and radiation. Relapse and refused further treatment. OS > 8 months |
| Mora and Wollner [7] | 1999 | 9/M | Epidural T9-11 mass | Laminectomy, dex, radiation, and CHOP (substituting daunorubicin for doxorubicin). Recurrence and given chemotherapy via LSA3 protocol. Second recurrence, received palliative radiation. OS > 1 year |
| Spath-Schwalbe et al. [27] | 1999 | 40/M | Cerebellum and pons masses | MTX and WBRT. OS > 1 year |
| Wilkening et al. [28] | 2001 | 43/F | L2-3 epidural tumor involving the dura and cauda equina | Complete resection, radiation, IT MTX, and MTX with ifosfamide and CHOP (with dex substituted for prednisone). OS of >2 years |
| Monabati et al. [29] | 2002 | 49/F | Right parietal mass | Complete resection, CHOP, and craniospinal radiation. Refused further treatment. OS of >6 months |
| Daley et al. [30] | 2003 | 13/F | L1-2 epidural mass | Complete excision, CHOP with MTX, and IT MTX and cytarabine and steroids. OS of >5 years |
| Shehu [31] | 2003 | 8/M | Left temporal and right orbit masses | Cy, vincristine, and MTX with IT cytosine arabinoside. OS of 11 months |
| Abel et al. [32] | 2006 | 50/M | Central and right thalamus mass | Unknown |
| Gobbato et al. [15] | 2006 | 38/M | Right frontotemporoparietal subdural mass | Craniotomy. OS of 11 days |
| Kozáková et al. [33] | 2008 | 60/F | Sellar/pituitary mass | Complete resection |
| Gu et al. [34] | 2010 | 75/F | Third and left lateral ventricle masses | WBRT. OS of >9 months |
| Takasu et al. [35] | 2010 | 71/M | Hypothalamus and third ventricle mass | Partial resection and WBRT |
| Jiang et al. [36] | 2011 | 14/M | Right lateral ventricle mass | Complete resection, radiation, and MTX, vincristine, predisone, and leucovorin. OS of >18 months |
| Lim et al. [10] | 2011 | 43/F | Medulla oblongata mass, CSF involvement | MTX, vincristine, and procarbazine with IT MTX and WBRT. OS of 7 months |
| Akhaddar et al. [37] | 2012 | 13/F | Right infratemporal and cavernous/maxillary/sphenoethmoidal sinus mass | Chemotherapy |
| Jiang et al. [38] | 2012 | 69/M | Right temporal and occipital lobe, cervical spine, and cauda equina masses; CSF involvement | DLBCL/BL subtype. WBRT, spinal radiation with recurrence. HD MTX and cytarabine with rituximab |
| Yoon et al. [39] | 2012 | 10/M | Suprasellar, cerebellum, and 3rd ventricle masses; CSF involvement | HD MTX and cytarabine with IT cytarabine, MTX, and hydrocortisone. OS of >7 years |
| Yoon et al. [39] | 2012 | 32 m/M | Sellar mass extending to orbit/sphenoid, CSF involvement | HD MTX and cytarabine with IT cytarabine, MTX, and hydrocortisone. Relapse, treated with IT cytarabine, MTX, and hydrocortisone with WBRT and spinal radiation. Then received prednisone, vincristine, and cyclophosphamide with IT. OS of 9 months |
| Alabdulsalam et al. [40] | 2014 | 18/M | 4th ventricle mass | Craniotomy with HD MTX with rituximab-CHOP and IT MTX, cytarabine, and hydrocortisone. OS of >18 months |
|
